Adaptimmune Therapeutics PLC (NASDAQ:ADAP)

2.39
Delayed Data
As of Aug 12
 +0.14 / +6.22%
Today’s Change
1.26
Today|||52-Week Range
6.86
-36.27%
Year-to-Date
No recent news for Adaptimmune Therapeutics PLC.

Today’s Trading

Previous close2.25
Today’s open2.35
Day’s range2.35 - 2.53
Volume40,381
Average volume (3 months)473,292
Market cap$401.9M
Data as of 3:59pm ET, 08/12/2022

Growth & Valuation

Earnings growth (last year)-10.25%
Earnings growth (this year)-583.82%
Earnings growth (next 5 years)+5.60%
Revenue growth (last year)+54.14%
P/E ratioNM
Price/Sales95.03
Price/Book1.87

Competitors

 Today’s
change
Today’s
% change
XXII22nd Century Group I...+0.01+0.83%
----
SELBSelecta Biosciences ...0.000.00%
TCRTAlaunos Therapeutics...-0.13-7.02%
Data as of 4:00pm ET, 08/12/2022

Financials

Next reporting dateNovember 9, 2022
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$6.1M
Annual profit (last year)-$158.1M
Net profit margin-2,570.99%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Abingdon, Oxfordshire

Forecasts